CLINICAL_TRIALS
trial_result
· 2013-08-28
Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1 [Phase 2]
Summary
A Phase 2 study evaluating lenalidomide for Complex Regional Pain Syndrome Type I was terminated, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene Corporation | Conditions: Complex Regional Pain Syndrome, Type I | Phase 2 | Status: TERMINATED | Results posted: 2013-08-28